Discontinued — last reported Q4 '24
Natera, Inc. Sequencing Services — Other Assets Noncurrent decreased by 14.6% to $4.10M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 16.3%, from $4.90M to $4.10M.
An increase may indicate significant long-term investment in proprietary technology or infrastructure, while a decrease could suggest asset impairment or the amortization of capitalized development costs.
This metric represents the long-term, non-current assets specifically allocated to the Sequencing Services business segm...
Peers in the molecular diagnostics space often report similar non-current assets related to capitalized R&D or long-term strategic partnerships.
ntra_segment_sequencing_services_other_assets_noncurrent| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|
| Value | $6.00M | $7.30M | $6.00M | $4.90M | $4.80M | $4.10M |
| QoQ Change | — | +21.7% | -17.8% | -18.3% | -2.0% | -14.6% |
| YoY Change | — | — | — | — | -20.0% | -16.3% |